DrugPatentWatch Database Preview

Arbor Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for ARBOR PHARMS LLC, and when can generic versions of ARBOR PHARMS LLC drugs launch?

ARBOR PHARMS LLC has twenty-two approved drugs.

There are nineteen US patents protecting ARBOR PHARMS LLC drugs.

There are two hundred and sixty-eight patent family members on ARBOR PHARMS LLC drugs in forty-two countries and twenty-six supplementary protection certificates in fourteen countries.

Summary for Arbor Pharms Llc

International Patents:	268
US Patents:	19
Tradenames:	23
Ingredients:	15
NDAs:	22

Drugs and US Patents for Arbor Pharms Llc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Arbor Pharms Llc	DEXTROAMPHETAMINE SULFATE	dextroamphetamine sulfate	TABLET;ORAL	090533-004	Oct 25, 2011	AA	RX	No	No
Arbor Pharms Llc	BIDIL	hydralazine hydrochloride; isosorbide dinitrate	TABLET;ORAL	020727-001	Jun 23, 2005		RX	Yes	Yes	6,465,463
Arbor Pharms Llc	DEXTROAMPHETAMINE SULFATE	dextroamphetamine sulfate	TABLET;ORAL	090533-002	Oct 25, 2011	AA	RX	No	No
Arbor Pharms Llc	EDARBI	azilsartan kamedoxomil	TABLET;ORAL	200796-001	Feb 25, 2011		RX	Yes	No	9,066,936		Y

Expired US Patents for Arbor Pharms Llc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Arbor Pharms Llc	BIDIL	hydralazine hydrochloride; isosorbide dinitrate	TABLET;ORAL	020727-001	Jun 23, 2005	4,868,179
Arbor Pharms Llc	GLIADEL	carmustine	IMPLANT;INTRACRANIAL	020637-001	Sep 23, 1996	5,179,189
Arbor Pharms Llc	GLIADEL	carmustine	IMPLANT;INTRACRANIAL	020637-001	Sep 23, 1996	4,757,128
Arbor Pharms Llc	EDARBI	azilsartan kamedoxomil	TABLET;ORAL	200796-002	Feb 25, 2011	5,736,555

Paragraph IV (Patent) Challenges for ARBOR PHARMS LLC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Lotion	0.5%		2017-09-01

Non-Orange Book US Patents for Arbor Pharms Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,906,412	GABA analog prodrug sustained release oral dosage forms
8,168,623	Prodrugs of GABA analogs, compositions and uses thereof
7,186,855	Prodrugs of GABA analogs, compositions and uses thereof
6,833,140	Orally administered dosage forms of GABA analog prodrugs having reduced toxicity

International Patents for Arbor Pharms Llc Drugs

Country	Document Number	Estimated Expiration
European Patent Office	1569895
Brazil	PI0809522
Taiwan	I474841
World Intellectual Property Organization (WIPO)	2010013835

Supplementary Protection Certificates for Arbor Pharms Llc Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1718641/01	Switzerland		PRODUCT NAME: AZILSARTAN MEDOXOMIL; REGISTRATION NO/DATE: SWISSMEDIC 62158 31.08.2012
2012 00013	Denmark
915	Luxembourg		PRODUCT NAME: IVERMECTINE POUR SON USAGE DANS LE TRAITEMENT DE LA ROSACEA; FIRST REGISTRATION: 20150402
C/GB01/013	United Kingdom		PRODUCT NAME: N,N'-BIS(2-CHLOROETHYL)-N-NITROSO-UREA (CARMUSTINE) COMBINED WITH A POLYANHYDRIDE HAVING A WEIGHT AVERAGE MOLECULAR WEIGHT OF GREATER THAN 20,000 PREPARED BY THE POLYCONDENSATION OF: (I) 4,4'-(TRIMETHYLENEDIOXY)-DIBENZOIC ACID; AND (II) SEBACIC ACID (POLI; REGISTERED: FR 561 907-5 19990105; UK PL 00012/0337 20000928

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Arbor Pharms Inc
• Arbor Pharms Llc